Tesamorelin / Ipamorelin 13 mg (10/3)

TI-2026-002Lot Not providedAnalyzed November 7, 2026

Timeline

Ordered

November 3, 2026

Received

November 5, 2026

Analyzed

November 7, 2026

Sample

Name

Tesamorelin / Ipamorelin 13 mg (10/3)

Expected

Tesamorelin + Ipamorelin

Amount

1 vial, lyophilized powder

Testing

Client

4ver Research

Test type

Content & purity

Method

HPLC-UV

Content, how much is in it

Tesamorelin9.73mg

Label claim: 10 mg

Ipamorelin4.63mg

Label claim: 3 mg

Purity, how clean it is

99.9%

by HPLC-UV peak area, system peaks excluded

Chromatogram

HPLC-UV

8.67 min, Ipamorelin, 99.9%

13.57 min, Tesamorelin, 99.9%

Analyst Comments

White lyophilized powder, blue-cap vial, received sealed.

Analyst Signature

Max Barrett

Lab Director, PuriLab Analytical

Analysis date: November 7, 2026

Verification Code

TI-8QG1-WI2G

Verify at purilab.org/verify/TI-8QG1-WI2G

Scan to Verify

TI-8QG1-WI2G

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analytical|admin@purilab.org

Page 1 of 1